Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 1 Issue: 3, November

Preface

Volume:1   Issue: 3
Pp: i-i
Ruiwen Zhang
DOI: 10.2174/1568009013334179
Published on: 01 March, 2012

Antisense Anticancer Oligonucleotide Therapeutics

Volume:1   Issue: 3
Pp: 177-196
Hui Wang, Gautam Prasad, John K. Buolamwini and Ruiwen Zhang
DOI: 10.2174/1568009013334133
Published on: 01 March, 2012

Antisense and/or Immunostimulatory Oligonucleotide Therapeutics

Volume:1   Issue: 3
Pp: 197-209
Sudhir Agrawal and Ekambar R. Kandimalla
DOI: 10.2174/1568009013334160
Published on: 01 March, 2012

Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases

Volume:1   Issue: 3
Pp: 211-230
D. R. Mercatante, P. Sazani and R. Kole
DOI: 10.2174/1568009013334124
Published on: 01 March, 2012

Targeting of Cancer-Related Proteins with PNA Oligomers

Volume:1   Issue: 3
Pp: 231-239
Margus Pooga and Ulo Langel
DOI: 10.2174/1568009013334142
Published on: 01 March, 2012

D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections.

Volume:1   Issue: 3
Pp: 241-247
Shi-Lung Lin and Shao-Yao Ying
DOI: 10.2174/1568009013334151
Published on: 01 March, 2012